ERBB2 and neoplasm: HER2-E tumours were associated with higher grade (68·6% grade 3 in HER2-E vs 30·9% in luminals, p<0·0001, Fisher test) and larger tumours (50·3% >3 cm in HER2-E vs 39·1% in luminals, p<0·0001, Fisher test).